date:Sep 27, 2019
s Asia Pacific (APAC), Greater China (GC), and Africa, Middle East, Europe, North Asia, Americas (AMENA).
Continuing divestments
Another element of Fonterras strategy involves divesting non-core businesses instead of investing widely based on aggressive growth plans. The NZ$633 million sale of its DFE Pharma share and significant contribution from Tip Top will give the company NZ$1 billion available for debt reduction.
We have sold our share of DFE Pharma to CVC Strategic Opportunities II, a